vs
迈梭电子（MEI）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
迈梭电子的季度营收约是REPLIGEN CORP的1.2倍（$246.9M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -4.0%，领先10.7%），REPLIGEN CORP同比增速更快（13.6% vs -15.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $-11.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -2.5%）
迈梭电子是一家总部位于美国伊利诺伊州芝加哥的跨国企业，主要业务涵盖工程研发、生产制造与销售服务，目前在全球14个国家设有超过35个运营网点，全球员工总数约6500人。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
MEI vs RGEN — 直观对比
营收规模更大
MEI
是对方的1.2倍
$197.9M
营收增速更快
RGEN
高出29.3%
-15.6%
净利率更高
RGEN
高出10.7%
-4.0%
自由现金流更多
RGEN
多$29.2M
$-11.6M
两年增速更快
RGEN
近两年复合增速
-2.5%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $246.9M | $197.9M |
| 净利润 | $-9.9M | $13.3M |
| 毛利率 | 19.3% | 52.5% |
| 营业利润率 | 1.2% | 9.0% |
| 净利率 | -4.0% | 6.7% |
| 营收同比 | -15.6% | 13.6% |
| 净利润同比 | -518.8% | 143.9% |
| 每股收益（稀释后） | $-0.28 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MEIRGEN
| Q4 25 | $246.9M | $197.9M | ||
| Q3 25 | $240.5M | $188.8M | ||
| Q2 25 | $257.1M | $182.4M | ||
| Q1 25 | $239.9M | $169.2M | ||
| Q4 24 | $292.6M | $174.1M | ||
| Q3 24 | $258.5M | $154.9M | ||
| Q2 24 | $277.3M | $154.1M | ||
| Q1 24 | $259.5M | $151.3M |
净利润MEIRGEN
| Q4 25 | $-9.9M | $13.3M | ||
| Q3 25 | $-10.3M | $14.9M | ||
| Q2 25 | $-28.3M | $14.9M | ||
| Q1 25 | $-14.4M | $5.8M | ||
| Q4 24 | $-1.6M | $-30.3M | ||
| Q3 24 | $-18.3M | $-654.0K | ||
| Q2 24 | $-57.3M | $3.3M | ||
| Q1 24 | $-11.6M | $2.1M |
毛利率MEIRGEN
| Q4 25 | 19.3% | 52.5% | ||
| Q3 25 | 18.1% | 53.2% | ||
| Q2 25 | 7.6% | 50.0% | ||
| Q1 25 | 17.2% | 53.6% | ||
| Q4 24 | 19.8% | 26.1% | ||
| Q3 24 | 17.3% | 50.0% | ||
| Q2 24 | 12.8% | 49.8% | ||
| Q1 24 | 14.3% | 49.5% |
营业利润率MEIRGEN
| Q4 25 | 1.2% | 9.0% | ||
| Q3 25 | 0.5% | 8.9% | ||
| Q2 25 | -9.2% | 7.6% | ||
| Q1 25 | -0.9% | 3.9% | ||
| Q4 24 | 3.2% | -17.7% | ||
| Q3 24 | -2.9% | -5.1% | ||
| Q2 24 | -22.2% | 1.0% | ||
| Q1 24 | -1.2% | 1.3% |
净利率MEIRGEN
| Q4 25 | -4.0% | 6.7% | ||
| Q3 25 | -4.3% | 7.9% | ||
| Q2 25 | -11.0% | 8.2% | ||
| Q1 25 | -6.0% | 3.4% | ||
| Q4 24 | -0.5% | -17.4% | ||
| Q3 24 | -7.1% | -0.4% | ||
| Q2 24 | -20.7% | 2.2% | ||
| Q1 24 | -4.5% | 1.4% |
每股收益（稀释后）MEIRGEN
| Q4 25 | $-0.28 | $0.24 | ||
| Q3 25 | $-0.29 | $0.26 | ||
| Q2 25 | $-0.79 | $0.26 | ||
| Q1 25 | $-0.41 | $0.10 | ||
| Q4 24 | $-0.05 | $-0.55 | ||
| Q3 24 | $-0.52 | $-0.01 | ||
| Q2 24 | $-1.62 | $0.06 | ||
| Q1 24 | $-0.33 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $118.5M | $767.6M |
| 总债务越低越好 | $332.5M | $542.2M |
| 股东权益账面价值 | $679.3M | $2.1B |
| 总资产 | $1.3B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.49× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资MEIRGEN
| Q4 25 | $118.5M | $767.6M | ||
| Q3 25 | $121.1M | $748.7M | ||
| Q2 25 | $103.6M | $708.9M | ||
| Q1 25 | $103.8M | $697.2M | ||
| Q4 24 | $97.0M | $757.4M | ||
| Q3 24 | $111.3M | $784.0M | ||
| Q2 24 | $161.5M | $809.1M | ||
| Q1 24 | $122.9M | $780.6M |
总债务MEIRGEN
| Q4 25 | $332.5M | $542.2M | ||
| Q3 25 | $323.4M | $537.9M | ||
| Q2 25 | $317.6M | — | ||
| Q1 25 | $327.9M | — | ||
| Q4 24 | $340.6M | $525.6M | ||
| Q3 24 | $296.0M | — | ||
| Q2 24 | $330.9M | — | ||
| Q1 24 | $331.3M | — |
股东权益MEIRGEN
| Q4 25 | $679.3M | $2.1B | ||
| Q3 25 | $688.1M | $2.1B | ||
| Q2 25 | $693.3M | $2.1B | ||
| Q1 25 | $704.3M | $2.0B | ||
| Q4 24 | $738.3M | $2.0B | ||
| Q3 24 | $744.4M | $2.0B | ||
| Q2 24 | $766.0M | $2.0B | ||
| Q1 24 | $835.0M | $2.0B |
总资产MEIRGEN
| Q4 25 | $1.3B | $2.9B | ||
| Q3 25 | $1.3B | $2.9B | ||
| Q2 25 | $1.3B | $2.9B | ||
| Q1 25 | $1.3B | $2.9B | ||
| Q4 24 | $1.4B | $2.8B | ||
| Q3 24 | $1.4B | $2.8B | ||
| Q2 24 | $1.4B | $2.9B | ||
| Q1 24 | $1.5B | $2.8B |
负债/权益比MEIRGEN
| Q4 25 | 0.49× | 0.26× | ||
| Q3 25 | 0.47× | 0.26× | ||
| Q2 25 | 0.46× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.46× | 0.27× | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.43× | — | ||
| Q1 24 | 0.40× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-7.4M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-11.6M | $17.6M |
| 自由现金流率自由现金流/营收 | -4.7% | 8.9% |
| 资本支出强度资本支出/营收 | 1.7% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $52.3M | $93.9M |
8季度趋势，按日历期对齐
经营现金流MEIRGEN
| Q4 25 | $-7.4M | $25.7M | ||
| Q3 25 | $25.1M | $48.1M | ||
| Q2 25 | $35.4M | $28.6M | ||
| Q1 25 | $28.1M | $15.0M | ||
| Q4 24 | $-48.0M | $39.2M | ||
| Q3 24 | $10.9M | $49.3M | ||
| Q2 24 | $24.9M | $42.2M | ||
| Q1 24 | $28.8M | $44.7M |
自由现金流MEIRGEN
| Q4 25 | $-11.6M | $17.6M | ||
| Q3 25 | $18.0M | $43.4M | ||
| Q2 25 | $26.3M | $21.5M | ||
| Q1 25 | $19.6M | $11.4M | ||
| Q4 24 | $-58.4M | $33.6M | ||
| Q3 24 | $-2.7M | $42.3M | ||
| Q2 24 | $15.8M | $37.4M | ||
| Q1 24 | $12.2M | $36.4M |
自由现金流率MEIRGEN
| Q4 25 | -4.7% | 8.9% | ||
| Q3 25 | 7.5% | 23.0% | ||
| Q2 25 | 10.2% | 11.8% | ||
| Q1 25 | 8.2% | 6.8% | ||
| Q4 24 | -20.0% | 19.3% | ||
| Q3 24 | -1.0% | 27.3% | ||
| Q2 24 | 5.7% | 24.3% | ||
| Q1 24 | 4.7% | 24.0% |
资本支出强度MEIRGEN
| Q4 25 | 1.7% | 4.1% | ||
| Q3 25 | 3.0% | 2.5% | ||
| Q2 25 | 3.5% | 3.9% | ||
| Q1 25 | 3.5% | 2.1% | ||
| Q4 24 | 3.6% | 3.2% | ||
| Q3 24 | 5.3% | 4.5% | ||
| Q2 24 | 3.3% | 3.1% | ||
| Q1 24 | 6.4% | 5.5% |
现金转化率MEIRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
